Search Results for agency_names:"Centers for Disease Control and Prevention"

The Centers for Disease Control and Prevention (CDC) is seeking public comments on their study titled “Medication-Assisted Treatment (MAT) for Opioid Use Disorder,” which is under review by the Office of Management and Budget (OMB). This study aims to evaluate the effectiveness of different treatments for opioid use disorders, which affect about 2.4 million adults in the U.S. The CDC has extended the recruitment deadline due to lower than expected patient enrollment and requires OMB approval to continue data collection. The public can submit comments or suggestions concerning the necessity, methodology, and cost of the proposed information collection within 30 days of the notice's publication.

The Centers for Disease Control and Prevention (CDC) has submitted a request to extend a program that collects feedback on its services, seeking approval from the Office of Management and Budget (OMB). The feedback aims to improve CDC service delivery by gathering customer insights through a non-statistical method. This extension is part of the CDC's ongoing efforts to enhance service quality, as required by Executive Order 12862. The CDC is inviting public comments on the proposal and expects to continue the program for three more years, following approval.

The Centers for Disease Control and Prevention (CDC) is seeking public feedback on their "Operational Readiness Review 2.0" information collection project, as part of compliance with the Paperwork Reduction Act. This project assesses the public health emergency preparedness of 62 jurisdictions, including major cities, to ensure they are ready to handle health emergencies. The public has 30 days to provide comments on whether the information collected is essential, accurate, and efficient. The CDC uses this data to identify strengths and challenges in preparedness programs and improve responses to public health threats.

The Centers for Disease Control and Prevention (CDC) announced a closed meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel. This meeting, scheduled for April 28, 2021, will be held via teleconference from 11:00 a.m. to 6:00 p.m. EDT. The purpose is to review and evaluate grant applications, which contain confidential information such as trade secrets and personal data. Due to the sensitive nature of the materials, the meeting will not be open to the public.

The Centers for Disease Control and Prevention (CDC) is seeking public comments on a proposal concerning the collection of information related to COVID-19 tests for airline passengers entering the United States. This proposal requires passengers to present either a negative COVID-19 test taken within three days before their flight or documentation of recovery from the virus. There are some exemptions, such as for certain federal personnel and urgent humanitarian cases. The CDC aims to prevent COVID-19 transmission while acknowledging the potential costs and efforts involved in implementing these requirements.

The Centers for Disease Control and Prevention (CDC) has submitted a request to the Office of Management and Budget (OMB) to review an information collection project titled “Menthol-Flavored Tobacco Product Policy Evaluation.” This evaluation aims to study the impact of local policies that restrict the sale of menthol tobacco products on tobacco use and behavior, especially among diverse groups like LGBTQ+ individuals and racial minorities. The CDC seeks public comments on the necessity and impact of this information collection, emphasizing minimizing respondent burden through technological means. The project will gather data for three years and has no costs to respondents other than their participation time.

The Centers for Disease Control and Prevention (CDC) announced a closed meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel. The meeting is scheduled for March 4, 2025, and will be held via video conference. The purpose of this meeting is to review and evaluate grant applications related to Occupational Safety and Health Training Project Grants. Due to the potential disclosure of confidential or personal information, the meeting will not be open to the public.

The Centers for Disease Control and Prevention (CDC) announced a change in the schedule of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel meeting. Originally planned as a two-day event, it will now occur on February 25, 2025, from 10 a.m. to 5 p.m. EST via web conference. This meeting, dedicated to identifying and evaluating potential risk factors for ALS, will be closed to the public. The announcement was issued under the authority of the Director of the Office of Strategic Business Initiatives at the CDC.

The Centers for Disease Control and Prevention (CDC) announced a closed meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel. The meeting will be held virtually from April 26-29, 2021, from 11:00 a.m. to 6:00 p.m. EDT. It will focus on reviewing and evaluating grant applications related to NIOSH Centers of Excellence for Total Worker Health. The meeting is closed to the public to protect confidential information and personal privacy associated with the grant applications.

The Centers for Disease Control and Prevention (CDC) is asking for feedback on whether nurse practitioners and physician assistants should be allowed to take the NIOSH B Reader examination to be certified to assess chest radiographs for dust-induced lung diseases. Right now, only licensed physicians can become B Readers. The CDC wants input from health experts, industry, and workers on potential benefits and risks of this change, and how it might improve health monitoring across different areas and populations. They are accepting comments until March 17, 2025.